SELAS PHARMACIE DE LA PORTE DE MONTREUIL : revenue, balance sheet and financial ratios

SELAS PHARMACIE DE LA PORTE DE MONTREUIL is a French company founded 9 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in PARIS (75020), this company of category PME shows in 2024 a revenue of 8.6 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELAS PHARMACIE DE LA PORTE DE MONTREUIL (SIREN 822523098)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue 8 619 669 € 8 771 703 € 4 801 331 € 8 950 336 € 8 217 622 € 8 845 224 € 11 908 849 € N/C N/C
Net income 558 376 € 648 313 € 458 797 € 980 406 € 141 242 € 379 842 € -605 210 € -60 957 € -13 538 €
EBITDA 985 091 € 974 943 € 593 464 € 1 590 732 € 856 956 € 1 136 696 € 592 014 € -24 126 € -9 636 €
Net margin 6.5% 7.4% 9.6% 11.0% 1.7% 4.3% -5.1% N/C N/C

Revenue and income statement

En 2024, SELAS PHARMACIE DE LA PORTE DE MONTREUIL alcanza unos ingresos de 8.6 M€. Los ingresos disminuyen en el período 2018-2024 (TCAC: -5.2%). Ligera caída de -2% vs 2023. Tras deducir el consumo (5.7 M€), el margen bruto se sitúa en 2.9 M€, es decir, una tasa del 34%. El EBITDA alcanza 985 k€, representando el 11.4% de los ingresos. Este nivel de margen operativo es satisfactorio para el sector. El resultado neto asciende a 558 k€, es decir, el 6.5% de los ingresos.

Revenue (2024) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

8 619 669 €

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

2 946 085 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

985 091 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

1 030 289 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

558 376 €

EBITDA margin (2024) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

11.4%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

El ratio de endeudamiento (= Deuda financiera / Fondos propios x 100) se sitúa en 1025%. Situación crítica: la deuda supera significativamente los fondos propios. La autonomía financiera (= Fondos propios / Total activo x 100) alcanza el 8%. Baja autonomía: la empresa depende fuertemente de financiación externa. La capacidad de reembolso indica que se necesitarían 16.3 años de flujo de caja. Más allá de 7 años, los bancos generalmente consideran el riesgo crediticio como alto. El flujo de caja representa el 6.6% de los ingresos. Nivel satisfactorio que permite financiar parcialmente el crecimiento.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

1024.758%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

8.116%

Cash flow / Revenue (2024) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

6.637%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

16.274

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

9.4%

Solvency indicators evolution
SELAS PHARMACIE DE LA PORTE DE MONTREUIL

Sector positioning

Ratio de endeudamiento
1024.76 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average

En 2024, el ratio de endeudamiento de SELAS PHARMACIE DE LA POR... (1024.76) se sitúa por encima de la mediana del sector. Este ratio mide el peso de la deuda en relación con el patrimonio. Un esfuerzo de reducción podría mejorar la solidez financiera.

Autonomía financiera
8.12% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Vigilar

En 2024, el autonomía financiera de SELAS PHARMACIE DE LA POR... (8.1%) se sitúa en el 25% más bajo del sector. Este ratio representa la parte del patrimonio en la financiación total. Baja autonomía puede limitar la capacidad de inversión y aumentar la vulnerabilidad.

Capacidad de reembolso
16.27 ans 2024
2022
2023
2024
Q1: 0.52 ans
Med: 3.19 ans
Q3: 7.6 ans
Vigilar

En 2024, el capacidad de reembolso de SELAS PHARMACIE DE LA POR... (16.3 ans) se sitúa en el top 25% del sector. Este ratio indica el número de años necesarios para pagar la deuda con flujo de caja. Una duración larga puede señalar deuda pesada relativa a la capacidad de pago.

Liquidity ratios

El ratio de liquidez se sitúa en 121.78. La empresa tiene 2€ de activos líquidos por cada 1€ de deuda a corto plazo. El ratio de cobertura de intereses (= EBIT / Gastos financieros) es de 25.7x. El resultado de explotación cubre muy ampliamente los gastos financieros.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

121.781

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

25.706

Liquidity indicators evolution
SELAS PHARMACIE DE LA PORTE DE MONTREUIL

Sector positioning

Ratio de liquidez
121.78 2024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Vigilar

En 2024, el ratio de liquidez de SELAS PHARMACIE DE LA POR... (121.78) se sitúa en el 25% más bajo del sector. Este ratio mide la capacidad de cubrir deuda a corto plazo con activos corrientes. Un ratio inferior a 1 puede señalar tensiones potenciales de flujo de caja.

Cobertura de intereses
25.71x 2024
2022
2023
2024
Q1: 0.0x
Med: 2.35x
Q3: 7.73x
Excelente

En 2024, el cobertura de intereses de SELAS PHARMACIE DE LA POR... (25.7x) se sitúa en el top 25% del sector. Este ratio indica cuántas veces el resultado operativo cubre los gastos de intereses. Alta cobertura significa que los gastos financieros pesan poco en la rentabilidad.

Working capital requirement (WCR) and payment terms

El fondo de maniobra operativo (FM) mide el desfase temporal de tesorería. Plazo medio de cobro a clientes: 7 días. Plazo proveedores: 42 días. Excelente situación: los proveedores financian 35 días del ciclo operativo. La rotación de existencias es de 28 días. Rotación rápida, señal de buena gestión de existencias. El FM representa 29 días de ingresos.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

695 693 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

7 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

42 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

28 j

WCR in days of revenue (2024) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

29 j

WCR and payment terms evolution
SELAS PHARMACIE DE LA PORTE DE MONTREUIL

Positioning of SELAS PHARMACIE DE LA PORTE DE MONTREUIL in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SELAS PHARMACIE DE LA PORTE DE MONTREUIL is estimated at 7 761 620 € (range 5 451 680€ - 11 488 579€). With an EBITDA of 985 091€, the sector multiple of 9.2x is applied. The price/revenue ratio is 0.64x (in line with sector norms). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
5451k€ 7761k€ 11488k€
7 761 620 € Range: 5 451 680€ - 11 488 579€
NAF 5 année 2024

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
985 091 € × 9.2x
Estimation 9 096 786 €
5 958 800€ - 14 143 630€
Revenue Multiple 30%
8 619 669 € × 0.64x
Estimation 5 513 864 €
4 621 900€ - 6 947 697€
Net Income Multiple 20%
558 376 € × 14.0x
Estimation 7 795 342 €
5 428 553€ - 11 662 277€

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELAS PHARMACIE DE LA PORTE DE MONTREUIL with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELAS PHARMACIE DE LA PORTE DE MONTREUIL

What is the revenue of SELAS PHARMACIE DE LA PORTE DE MONTREUIL ?

The revenue of SELAS PHARMACIE DE LA PORTE DE MONTREUIL in 2024 is 8.6 M€.

Is SELAS PHARMACIE DE LA PORTE DE MONTREUIL profitable?

Yes, SELAS PHARMACIE DE LA PORTE DE MONTREUIL generated a net profit of 558 k€ in 2024.

Where is the headquarters of SELAS PHARMACIE DE LA PORTE DE MONTREUIL ?

The headquarters of SELAS PHARMACIE DE LA PORTE DE MONTREUIL is located in PARIS (75020), in the department Paris.

Where to find the tax return of SELAS PHARMACIE DE LA PORTE DE MONTREUIL ?

The tax return of SELAS PHARMACIE DE LA PORTE DE MONTREUIL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELAS PHARMACIE DE LA PORTE DE MONTREUIL operate?

SELAS PHARMACIE DE LA PORTE DE MONTREUIL operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.